All human Schlafen mRNA expression was induced in normal melanocytes by IFN therapy, while only SLFN5 was induced in malignant melanoma cells and renal cell carcinoma cells [8,40]. The gene discussed is SLFN5; the disease is hereditary clear cell renal cell carcinoma.